Laquinimod (ABR-215062) suppresses the development of experimental autoimmune encephalomyelitis, modulates the Th1/Th2 balance and induces the Th3 cytokine TGF-beta in Lewis rats

Author(s): Yang JS, Xu LY, Xiao BG, Hedlund G, Link H

Abstract

The new orally active drug laquinimod (ABR-215062) was evaluated in experimental autoimmune encephalomyelitis (EAE) in the Lewis rat. EAE shares important immunological and clinical features with multiple sclerosis (MS). Doses of 16, 1.6 and 0.16 mg/kg/day laquinimod dose-dependently inhibited disease and showed better disease inhibitory effects as compared to roquinimex (Linomide). Furthermore, laquinimod inhibited the inflammation of both CD4+ T cells and macrophages into central nervous tissues, i.e. the spinal cord. It also changed the cytokine balance in favour of TH2/TH3 cytokines IL-4, IL-10 and TGF-beta. Laquinimod therefore represents a new orally active immunoregulatory drug without general immunosuppressive properties with a potential for the treatment of severe autoimmune diseases like MS.

Similar Articles

Disruption of Cnp1 uncouples oligodendroglial functions in axonal support and myelination

Author(s): Lappe-Siefke C, Goebbels S, Gravel M, Nicksch E, Lee J, et al.

Axonal swellings and degeneration in mice lacking the major proteolipid of myelin

Author(s): Griffiths I, Klugmann M, Anderson T, Yool D, Thomson C, et al.

Proteolipid protein is required for transport of sirtuin 2 into CNS myelin

Author(s): Werner HB, Kuhlmann K, Shen S, Uecker M, Schardt A, et al.

Oligodendroglial modulation of fast axonal transport in a mouse model of hereditary spastic paraplegia

Author(s): Edgar JM, McLaughlin M, Yool D, Zhang SC, Fowler JH, et al.

NG2-glia as multipotent neural stem cells: fact or fantasy? Neuron 70: 661-673

Author(s): Richardson WD, Young KM, Tripathi RB, McKenzie I

The response of NG2-expressing oligodendrocyte progenitors to demyelination in MOG-EAE and MS

Author(s): Reynolds R, Dawson M, Papadopoulos D, Polito A, Di Bello IC, et al.

NG2-positive oligodendrocyte progenitor cells in adult human brain and multiple sclerosis lesions

Author(s): Chang A, Nishiyama A, Peterson J, Prineas J, Trapp BD

Oligodendrocyte progenitors are present in the normal adult human CNS and in the lesions of multiple sclerosis

Author(s): Scolding N, Franklin R, Stevens S, Heldin CH, Compston A, et al.

Origin of oligodendrocytes in the subventricular zone of the adult brain

Author(s): Menn B, Garcia-Verdugo JM, Yaschine C, Gonzalez-Perez O, Rowitch D, et al.

Cdk2 loss accelerates precursor differentiation and remyelination in the adult central nervous system

Author(s): Caillava C, Vandenbosch R, Jablonska B, Deboux C, Spigoni G, et al.

Inhibition of CNS remyelination by the presence of semaphorin 3A

Author(s): Syed YA, Hand E, Möbius W, Zhao C, Hofer M, et al.

Dysregulation of the Wnt pathway inhibits timely myelination and remyelination in the mammalian CNS

Author(s): Fancy SP, Baranzini SE, Zhao C, Yuk DI, Irvine KA, et al.

Axin2 as regulatory and therapeutic target in newborn brain injury and remyelination

Author(s): Fancy SP, Harrington EP, Yuen TJ, Silbereis JC, Zhao C, et al.

bHLH transcription factor Olig1 is required to repair demyelinated lesions in the CNS

Author(s): Arnett HA, Fancy SP, Alberta JA, Zhao C, Plant SR, et al.

F3/contactin acts as a functional ligand for Notch during oligodendrocyte maturation

Author(s): Hu QD, Ang BT, Karsak M, Hu WP, Cui XY, et al.

Notch receptor activation inhibits oligodendrocyte differentiation

Author(s): Wang S, Sdrulla AD, diSibio G, Bush G, Nofziger D, et al.

Retinoid X receptor gamma signaling accelerates CNS remyelination

Author(s): Huang JK, Jarjour AA, NaitOumesmar B, Kerninon C, Williams A, et al.

CXCR4 promotes differentiation of oligodendrocyte progenitors and remyelination

Author(s): Patel JR, McCandless EE, Dorsey D, Klein RS

Hyaluronan blocks oligodendrocyte progenitor maturation and remyelination through TLR2

Author(s): Sloane JA, Batt C, Ma Y, Harris ZM, Trapp B, et al.

The immunomodulator FTY720 has a direct cytoprotective effect in oligodendrocyte progenitors

Author(s): Coelho RP, Payne SG, Bittman R, Spiegel S, Sato-Bigbee C

Fingolimod (FTY720) enhances remyelination following demyelination of organotypic cerebellar slices

Author(s): Miron VE, Ludwin SK, Darlington PJ, Jarjour AA, Soliven B, et al.

BG-12 (dimethyl fumarate): a review of mechanism of action, efficacy, and safety

Author(s): Fox RJ, Kita M, Cohan SL, Henson LJ, Zambrano J, et al.

Quetiapinefumarate for the treatment of multiple sclerosis: focus on myelin repair

Author(s): Zhornitsky S, Wee Yong V, Koch MW, Mackie A, Potvin S, et al.

Rejuvenation of aged progenitor cells by exposure to a young systemic environment

Author(s): Conboy IM, Conboy MJ, Wagers AJ, Girma ER, Weissman IL, et al.

Semaphorin 3A and 3F: key players in myelin repair in multiple sclerosis? Brain 130: 2554-2565

Author(s): Williams A, Piaton G, Aigrot MS, Belhadi A, Théaudin M, et al.

Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis

Author(s): Chang A, Tourtellotte WW, Rudick R, Trapp BD

Multiple sclerosis: re-expression of a developmental pathway that restricts oligodendrocyte maturation

Author(s): John GR, Shankar SL, Shafit-Zagardo B, Massimi A, Lee SC, et al.

Notch1 signaling plays a role in regulating precursor differentiation during CNS remyelination

Author(s): Zhang Y, Argaw AT, Gurfein BT, Zameer A, Snyder BJ, et al.

Negative regulation of central nervous system myelination by polysialylated-neural cell adhesion molecule

Author(s): Charles P, Hernandez MP, Stankoff B, Aigrot MS, Colin C, et al.